[P2] Poster Discussion 2 (Even Numbers)

[P-80] Evaluating the safety of CRISPR/Cas9 engineered CYP19 triple-knockout strain vaccine candidate against Trypanosoma cruzi

^○Farzaneh Valanezhad¹, Jalal Alshaweesh¹, Bijay Kumar Jha², Abhay R Satoskar³, Bradford S McGwire² (1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Division of Infectious Disease, Department of Medicine, The Ohio State University, Columbus, Ohio, USA., 3.Department of Pathology, The Ohio State University, Columbus, Ohio, USA)